4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000950170-25-009204
Chief Accounting Officer sold 36 shares at an average $9.51 ($342)
From the SEC's structured data for this filing
Trades in this filing
Hagen Brett R · Chief Accounting Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-23 | Sale : show line 1 in the form | −32 | $9.45 | $303 | 2,932 | D |
| 2025-01-23 | Sale : show line 2 in the form | −4 | $9.94 | $40 | 2,928 | D |
| Open-market sales · 36 sh · avg $9.51 · $342 | ||||||
Loading xslF345X05/ownership.xml…